MedTrace Logo

Impact of Anaesthesiology Management on Paediatric Emergence Delirium Incidence

NCT04291820 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-07-27

No results posted yet for this study

Summary

Postoperative emergence delirium (ED) is a severe postoperative complication in paediatric anaesthesia. ED is defined as a state with psychomotor disturbance, perception disorder and state of excitation and anxiety. The incidence of ED in paediatric patients can be up to 80%. ED is associated with the increased morbidity of paediatric patients in the postoperative period. One of the potential triggers of ED is sevoflurane. Currently, there are only limited data about comparing the influence of anesthesiologic management on the ED incidence. The possible ED reduction could lead to reduced stay in a post-anaesthesia care unit (PACU), postoperative nausea and vomiting (PONV) incidence and the overall reduction of the postoperative adverse events incidence together with the higher satisfaction and the patients and the legal guardians.

Conditions

  • Emergence Delirium

Interventions

PROCEDURE

Intravenous induction and desflurane anaesthesia maintenance

Anaesthesia will be inducted with intravenous propofol + opioid and maintained with desflurane according to the BIS levels

PROCEDURE

Inhalation induction with sevoflurane and anaesthesia maintenance with sevoflurane

Anaesthesia will be inducted with sevoflurane and maintained with sevoflurane according to the BIS levels

Sponsors & Collaborators

  • Brno University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04291820 on ClinicalTrials.gov